Keywords
How to Cite
Abstract
The review focuses on the use of free-circulating DNA (fcDNA) of Epstein-Barr virus (EBV) and human papillomavirus (HPV) in the diagnosis of cancer. The results of researches of recent years indicate the perspective for the development of EBV and HPV scDNAs as diagnostic markers. Authors analyzed in details the contradictions in the various studies, indicating the need for standardization of research for the introduction of these new markers in clinical practice.References
Сенюта Н.Б., Игнатова А.В., Ломая М.В. и др. Вирус Эпштейна-Барр у больных раком носоглотки и здоровых лиц в двух географически р азличных регионах России // Инфекция и иммунитет. - 2017. - Т. 7. - С. 41-50.
Ahn S., Chan J., Zhang Z. et el. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. // JAMA Otolaryngol. Head Neck Surg. - 2014. - Vol. 140. - P. 846-854.
Alfieri S., Iacovelli N., Marceglia S. et al. Circulating pretreatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area // Oncotarget. - 2017. - Vol. 8. - P. 47780-47789.
Anker P, Mulcahy H., Qi Chen X. et al. Detection of drculating tumour DNA in the blood (plasma/serum) of cancer patients // Cancer Metastasis Rev. - 1999. - Vol. 18. - P. 65-73.
Campitelli M., Jeannot E., Peter M. et al. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in Cervical Cancer Patients // PLoS ONE. -2012. - Vol. 7(8). - e43393. - DOI: 10.1371/journal.pone.0043393
The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma // Nature. - 2014. - Vol. 513. - P 202-209.
Cao H., Banh A., Kwok S. Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients // Int. J. Radiat. Oncol. Biol. Phys. - 2012. - Vol. 82(3). - P e351-8. - DOI: 10.1016/j.ijrobp.2011.05.061
Capone R., Pai S., Koch W. et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma // Clin. Cancer Res. - 2000. - Vol. 6. - P. 4171-4175.
Chai R., Lambie D., Verma M., Punyadeera C. Current trends in the etiology and diagnosis of HPV-related head and neck cancers // Cancer Med. - 2015. - Vol. 4. - P. 596-607.
Chai R., Lim Y., Frazer I. et al. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients // BMC Cancer. - 2016. - Vol. 16. - P. 178.
Chan A., Hui E., Ngan R. et al. A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT) // J. Clin. Oncol. - 2017. - Vol. 35. - P. 6002.
Chan K., Leung S., Yeung S. et al. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients // Clin. Cancer Res. -2008. - Vol. 14. - P. 4809-4813.
Chan K., Woo J., King A. et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer // N. Engl. J. Med. - 2017. - Vol. 377. - P. 513- 22.
Chan K., Zhang J., Chan A. et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients // Cancer Res. -2003. - Vol. 63. - P. 2028-2032.
Cocuzza C., Martinelli M., Sina F. et al. Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia // PLoS ONE. - 2017. - Vol. 2(11). - P. e0188592.
Combita A., Gheit T., Gonzalez P. et al. Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia // Cancer Prev. Res. (Phila). - 2016. - Vol. 9. - P. 766-771.
Dennis Lo Y, Chan W., Ng E. et al. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma // Clin. Cancer Research. - 2001. - Vol. 7. - P. 1856-1859.
Dong S., Pai S., Rha S.-H. et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma // Cancer Epidemiol. Biomarkers Prev. - 2002. - Vol. 11. - P. 3-6.
Ducancelle A., Legrand M., Pivert A. et al. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions // Arch Gynecol Obstet. - 2014. - Vol. 290. - P. 299-308.
Gallagher A., Armstrong A., MacKenzie J. et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease // Int. J. Cancer. - 1999. - Vol. 84. - P. 442 - 448.
Guerrero-Preston R., Valle B., Jedlicka A. et al. Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell-free DNA from urine, using a panel of methylated human papilloma virus and host genes // Cancer Prev. Res. (Phila). - 2016. - Vol. 9. - P. 915-924.
Haverkos B., Huang Y., Gru A. et al. Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas // Int. J. Cancer. - 2017. - Vol. 140. - P. 1899-1906.
He S.-S., Wang Y, Bao Y et al. Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study // Cancer Med. - 2018. - Vol. 7. - P. 1110-1117.
Holmes A., Lameiras S., Jeannot E. et al. Mechanistic signatures of HPV insertions in cervical carcinomas // Genomic Medicine. - 2016. - Vol. 1. - P. 16004. -. DOI: 10.1038/npjgenmed.2016.4
Jeannot E., Becette V., Campitelli M. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma // J. Path.: Clin. Res. - 2016. - Vol. 2. - P. 201-209.
Kang Z., Stevanovic S., Hinrichs C., Cao L. Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring // Clin. Cancer Res. -2017. - Vol. 23. - P. 6856-6862.
Keer S., Tjalma W., Pattyn J. et al. Human papillomavirus genotype and viral load agreement between paired firstvoid urine and clinician-collected cervical samples // Eur. J. Clin. Microbiol. Infect. Dis. - 2018. - Vol. 37. - P. 859-869.
Lam W., Jiang P., Chan K. et al. Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma // PNAS Latest Articles. - 2018. - P. 1-10.
Lee J., Garcia-Murillas I., Cutts R. et al. Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma // Br. J. Cancer. - 2017. - Vol. 117. - P. 876-883.
Lei K., Chan L., Chan W. et al. Quantitative analysis of circulating cell-free Epstein Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies // Br. J. Haematol. - 2000. - Vol. 111. - P. 239-246.
Lévy P., Bartosch B. Metabolic reprogramming: a hallmark of viral Oncogenesis // Oncogene. - 2016. - Vol. 35. - P. 4155-4164.
Limaye A., Huang M., Atienza E. et al. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders // J. Clin. Microbiol. -1999. -Vol. 37. - P. 1113-1116.
Lin J.-C., Wang W.-Y., Chen K. et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma // N. Engl. J. Med. - 2004. -Vol. 350. - P. 2461-2470.
Liu T., Zheng Z., Pan J. et al. Prognostic role of plasma Epstein-Barr virus DNA load for nasopharyngeal carcinoma: a meta-analysis // Clin. Invest. Med. - 2017. - Vol. 40. - P. E1-E12.
Liu V., Tsang P., Yip A. et al. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients // Gynecol. Oncol. - 2001. - Vol. 82. - P. 269-272.
Li Y, Khin N., Chua M. The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma // Cancer Biol. Med. - 2018. - DOI: 10.20892/j.issn.2095-3941.2017.0176
Lo Y, Chan L., Lo K. et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma // Cancer Res. - 1999. - Vol. 59. - P. 1188-1191.
Lu T., Li J. Clinical applications of urinary cell-free DNA in cancer: current insights and promising future // Am J Cancer Res. - 2017. - Vol. 7. - P. 2318-2332.
Machado A., Da Silva Robaina M., Magalh es De Rezende L. et al. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas // Leuk. Lymphoma. - 2010. - Vol. 51. - P. 1020-1027.
Mallen-St Clair J., Alani M., Wang M., Srivastan E. Human papillomavirus in oropharyngeal cancer: The changing face of a disease // BBA. - 2016. - Vol. 1866. - P. 141-150.
Mazurek A., Rutkowski T., Fiszer-Kierzkowska A. et al. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients // Oral. Oncol. - 2016. - Vol. 54. - P. 36-41.
Mutirangura A., Pornthanakasem W., Theamboonlers A. et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma // Clin. Cancer Res. - 1998. -Vol. 4. - P. 665-669.
Nalliah S., Karikalan B., Kademane K. Multifaceted usage of HPV related tests and products in the management of cervical cancer // Asian Pac. J. Cancer Prev. - 2015. - Vol. 16. - P. 2145-2150.
Ngan R., Yip T., Cheng W.-W. et al. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease // Clin.Cancer Res. - 2002. - Vol. 8. - P. 986-994.
Peng H., Chen L., Chen Y-P. et al. The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database // PLoS ONE. - 2018. - Vol. 13(5). - P. e0196730. - DOI: 10.1371/journal.pone.0196730
Peng H., Guo R., Chen L. et al. Prognostic impact of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma treated using intensity-modulated radiation therapy // Sci. Rep. - 2016. - 22000. - DOI: 10.1038/srep22000
Rutkowski T., Mazurek A., Snietura M. et al. Post-Treatment circulating free HPV DNA as a marker of treatment outcome in patients with HPV-related propharyngeal cancer after radio(chemo)therapy // Cell. Mol. Med. - 2017. - Vol. 3. - № 2. - P. 12. - DOI: 10.21767/25735365.100035
Ryan J., Fan H., Swinnen L. et al. Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies // Diagn. Mol. Pathol. - 2004. - Vol. 13. - P. 61-68.
Sengar M., Chorghe S., Jadhav K. et al. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: plasma versus urine // Head Neck. - 2016. - Vol. - Suppl 1. - P. E1666-1673.
Shannon-Lowe C., Rickinson A., Bell A. Epstein-Barr virus-associated lymphomas // Phil. Trans. R. Soc. B. - 2017. - Vol. 372. - P. 20160271. - DOI: 10.1098/rstb.2016.0271
Shoda K., Ichikawa D., Fujita Y et al. Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer // Oncotarget. - 2017. - Vol. 8. -P. 28796-28804.
Song Y, Xiao H., Yang Z. et al. The predictive value of pre- and post-induction chemotherapy plasma EBV DNA level and tumor volume for the radiosensitivity of locally advanced nasopharingeal carcinoma // EXCLI Journal. - 2017. - Vol. 16. - P. 1268-1275.
Stevens S., Vervoort M., van den Brule A. et al. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR // J. Clini. Microbiol. - 1999. - Vol. 37. - P. 2852-2857.
Tshomo U., Franceschi S., Tshokey T. et al. Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan // Virology J. - 2017. - Vol. 14. - P. 74. - DOI: 10.1186/s12985-017-0744-2
Udager A., McHugh J. Human papillomavirus-associated neoplasms of the head аnd neck // Surg. Pathol. Clin. - 2017. - Vol. 10. - P. 35-55.
Vo H., Nei W., Hu M., Phyo W. Comparison of circulating tumour cells and circulating cell-free Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma undergoing radiotherapy // Sci. Rep. - 2016. - Vol. 6. - P.13. - DOI: 10.1038/s41598-016-0006-3
Wang L., Wang H., Wang J. et al. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase // Oncotarget. - 2015. - Vol. 6. - P. 30317-30326.
Wang Y., Springer S., Mulvey C. et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas // Sci. Transl. Med. - 2015. - Vol. 7(293). - P. 293ra104. - DOI: 10.1126/scitranslmed.aaa8507
Wasserman J., Rourke R., Purgina B. et al. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours // J. Otolaryngol. Head Neck Surg. - 2017. - Vol. 46. - P.3. - DOI: 10.1186/s40463-016-0179-6
Welch J., Schwartz C., Higman M. et al. Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma // Blood Adv. -2017. - Vol. 1. - P. 681-684.
Westmoreland K., Montgomery N., Stanley C. et al. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi // Int. J. Cancer. - 2017. - Vol. 140. - P. 2509-2516.
Xie M., Wu X., Wang F. et al. Clinical significance of plasma Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma (LELC) patients // J. Thorac. Oncol. - 2018. - Vol. 13. - P. 218-227.
Yang H., Liu V., Tsang P. et al. Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer // Int. J. Gynecol. Cancer. - 2004. - Vol. 14. - P. 903-910.
Yang L., Xie S., Feng X. et al. Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis // Sci. Rep. - 2015. - Vol. 5. - P. 14667. - DOI: 10.1038/srep14667
Zambrano A., Kalantari M., Simoneau A. et al. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the Prostate as a habitat for multiple viral infections // Prostate. - 2002. - Vol. 53. - P. 263-276.
Zhang J., Shu C., Song Y et al. Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis // Medicine. - 2016. - Vol. 95. - P. 40(e5130). - DOI: 10.1097/MD.0000000000005130
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2019